Abstract |
Mitosis related Aurora-A kinase is amplified in a variety of carcinomas. Overexpression of Aurora-A contributes to tumorigenesis and disease progression, and has emerged as an attractive molecular target for the design of anticancer drugs. In this study, we investigated the function of Aurora-A selectively small molecule inhibitor VX-680 in nasopharyngeal carcinoma (NPC) CNE-2 cells. We found that VX-680 suppressed proliferation and induced apoptosis of 2Dimensional (2D) cultured NPC CNE-2 cells. Moreover, CNE-2 cells formed a tumor-like cell mass in 3Dimensional (3D) matrix culture microenvironment, and the tumor mass formation could be impaired when pretreated with VX-680 for indicated time. Similarly, when adding VX-680 to preformed 3D CNE-2 tumor mass, the tight spatial tumor mass experienced apparent apoptotic cell death and consequently dissociated into individual dead cells, as detected by cleaved Caspase-3 immunofluorescence assay. The migration assay showed that VX-680 decreased NPC CNE-2 cell migration ability in a dose-dependent manner. Our further study revealed that X-ray irradiation and VX-680 upregulated p53 expression level as well as arrested cell cycle in G(2)/M, sensitized NPC CNE-2 cells to radiation and effectively resulted in cell death. In summary, our data indicated that Aurora-A small molecule inhibitor VX-680, potently destructed tumor formation and induced apoptosis, reduced cell migration and enhanced radiosensitivity, offering a promising therapeutic agent for human NPC.
|
Authors | Xiang-Bo Wan, Xin-Juan Fan, Ming-Yuan Chen, Jie Xu, Zi-Jie Long, Yi-Jun Hua, Hong Ji, Li Liu, Ming-Huang Hong, Yi-Xin Zeng, Quentin Liu |
Journal | Cancer biology & therapy
(Cancer Biol Ther)
Vol. 8
Issue 15
Pg. 1500-6
(Aug 2009)
ISSN: 1555-8576 [Electronic] United States |
PMID | 19502819
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Neoplasm Proteins
- Piperazines
- Protein Kinase Inhibitors
- tozasertib
- Aurora Kinases
- Protein Serine-Threonine Kinases
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Aurora Kinases
- Carcinoma
(enzymology, pathology)
- Cell Cycle
(drug effects)
- Cell Division
(drug effects)
- Cell Movement
(drug effects)
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Gene Expression Regulation, Neoplastic
(drug effects)
- Genes, p53
- Humans
- Nasopharyngeal Neoplasms
(enzymology, pathology)
- Neoplasm Proteins
(antagonists & inhibitors, physiology)
- Piperazines
(pharmacology)
- Protein Kinase Inhibitors
(pharmacology)
- Protein Serine-Threonine Kinases
(antagonists & inhibitors, physiology)
- Radiation Tolerance
(drug effects)
- Tumor Cells, Cultured
(drug effects, enzymology, radiation effects)
|